Psyllium Reduces Metabolic Syndrome Risk Factors

This article originally appeared here.
Share this content:
Psyllium Reduces Metabolic Syndrome Risk Factors
Psyllium Reduces Metabolic Syndrome Risk Factors

(HealthDay News) – Consumption of the fiber supplement psyllium correlates with reductions in risk factors for metabolic syndrome, according to a study published online August 5 in Obesity Reviews.

Sebely Pal, PhD, and Simone Radavelli-Bagatini, from Curtin University in Perth, Australia, reviewed the literature published from 1980 to 2012 to examine the effect of psyllium on risk factors for metabolic syndrome.

The researchers found that consumption of psyllium conferred benefits to several components of metabolic syndrome, including improved glucose levels, insulin response, blood pressure, and improved lipid profiles in humans and animals. In most studies, after consumption of psyllium, appetite was reported to decrease.

"Collectively, psyllium supplementation could be promoted to patients who present metabolic syndrome risk factors, such as hypercholesterolemia, hypertriglyceridemia, and hyperglycemia," the authors write. "It may also play a role in controlling body weight, body composition, appetite, and hypertension, but further investigation is still required."

Abstract
Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs